{"id":1491,"date":"2016-11-01T16:57:57","date_gmt":"2016-11-01T20:57:57","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=1491"},"modified":"2016-11-01T16:57:57","modified_gmt":"2016-11-01T20:57:57","slug":"secondaries-announced-11-01-2016","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-11-01-2016\/","title":{"rendered":"Secondaries announced 11.01.2016"},"content":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. <\/p>\n<p>Company:\tRedHill Biopharma Ltd.<br \/>\nSymbol:\tRDHL<br \/>\nPrice:\t\tLast trade $11.80<br \/>\nDescription:\tNo re-offer range available<br \/>\nTrade Date:\t11\/2<br \/>\nShares:\tTBD<br \/>\nUnderwriter(s)Roth Capital Partners, FBR<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company:\tVeracyte<br \/>\nSymbol:\tVCYT<br \/>\nPrice:\t\t7.13<br \/>\nDescription:\tNo re-offer range available<br \/>\nTrade Date:\t11\/2<br \/>\nShares:\t3.5 million<br \/>\nUnderwriter(s)Leerink Partners LLC, BTIG, LLC<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company:\tCrown Castle<br \/>\nSymbol:\tCCI<br \/>\nPrice:\t\tLast trade $89.94<br \/>\nDescription:\tre-offer $88.60-$89.00<br \/>\nTrade Date:\t11\/2<br \/>\nShares:\t11.35 million<br \/>\nUnderwriter(s)J.P. Morgan, Citigroup, Morgan Stanley<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company:\tNextEra Energy Partners, LP<br \/>\nSymbol:\tNEP<br \/>\nPrice:\t\tLast trade $125.89<br \/>\nDescription:\tNo re-offer range available<br \/>\nTrade Date:\t11\/2<br \/>\nShares:\t12 million<br \/>\nUnderwriter(s)Morgan Stanley, Goldman Sachs, BofA Merrill Lynch<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: RedHill Biopharma Ltd. Symbol: RDHL Price: Last trade $11.80 Description: No re-offer range available Trade Date: 11\/2 Shares: TBD Underwriter(s)Roth Capital[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[918,620,115,917],"class_list":["post-1491","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-cci","tag-nep","tag-rdhl","tag-vcyt"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1491","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=1491"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1491\/revisions"}],"predecessor-version":[{"id":1492,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1491\/revisions\/1492"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=1491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=1491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=1491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}